Joint Formulary & PAD

GP

Guideline Profile : Osteoporosis

Committee Recommendations (2)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed an updated Osteoporosis pathway for specialist (high cost) treatments.

Please note that algorithm 1 in the Osteoporosis Guidelines has not been updated.

The Osteoporosis guidelines have been reviewed and updated.

The guidelines are supported by two algorithms which have been extracted from the guideline and provided as separate documents (below) for ease of use:
Algorithm 1 - Treatment Pathway for adults
Algorithm 2 - Review of Long-term Bisphosphonate Therapy 

Calcium & vitamin D:
AdcalD3/ AccreteD3 twice daily formulations are the preferred calcium and vitamin D supplements.
Accrete D3 One a Day, Calci-D chewable tablets or theiCal-D3 chewable tablets are once daily options for patients with compliance issues.
 

Guideline Profile

Indication :
Osteoporosis
Keywords :
bisphosphonates, postmenopausal osteoporosis, bone density, abaloparatide, romosozumab, teriparatide
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
7